Clinical trial
A Prospective, Multicenter Clinical Investigation to Evaluate Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT)
NCT04519814 is registered in ClinicalTrials.gov with Carl Zeiss Meditec AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Clinical Investigation to Evaluate Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT)
- Lead sponsor
- Carl Zeiss Meditec AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2020
- Completion date
- September 13, 2022
- Enrollment
- 37 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
primary open-angle glaucoma